
Chinese General Practice ›› 2027, Vol. 30 ›› Issue (01): 66-72.DOI: 10.12114/j.issn.1007-9572.2025.0456
• Article • Previous Articles
Received:2025-12-20
Revised:2026-02-25
Published:2027-01-05
Online:2026-11-17
Contact:
Bi Yan
通讯作者:
毕艳
作者简介:作者贡献:
张璐负责采集数据、分析数据、起草文章及统计分析;张洲提出研究思路,设计研究方案,分析/解释数据,对文章的知识性内容进行批评性审阅、指导;于从从、巢怡宁、杨思珏、吴天宇、赵声易负责实施研究、采集数据;毕艳提出研究思路和设计研究方案,对文章的知识性内容进行批评性审阅、指导,完善论文最终内容审校,并对论文负责。
基金资助:CLC Number:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.chinagp.net/EN/10.12114/j.issn.1007-9572.2025.0456
| 项目 | 认知功能正常组(n=424) | 合并MCI组(n=639) | t(χ2)值 | P值 |
|---|---|---|---|---|
| 年龄( | 60.4±6.9 | 61.1±6.5 | -1.59 | 0.112 |
| 男性[例(%)] | 273(64.4) | 389(60.9) | 1.35a | 0.248 |
| 受教育年限( | 11.5±2.8 | 11.2±2.9 | -1.82 | 0.178 |
| 吸烟史[例(%)] | 131(30.9) | 208(32.6) | 0.32a | 0.571 |
| 饮酒史[例(%)] | 107(25.2) | 155(24.3) | 0.13a | 0.717 |
| 病程( | 10.5±7.7 | 10.6±7.4 | -0.13 | 0.897 |
| BMI( | 24.7±3.0 | 24.6±3.0 | 0.40 | 0.692 |
| WH R( | 0.93±0.07 | 0.93±0.06 | -0.01 | 0.992 |
| 收缩压( | 130±17 | 129±16 | 0.96 | 0.339 |
| 舒张压( | 81±10 | 80±10 | 1.05 | 0.293 |
| 合并高血压[例(%)] | 202(47.6) | 286(41.8) | 0.24a | 0.626 |
| 合并高脂血症[例(%)] | 184(43.4) | 250(39.1) | 0.01a | 0.930 |
| MoCA量表得分( | 27.1±1.2 | 23.3±1.8 | 42.41 | <0.001 |
| MMSE量表得分( | 28.6±1.2 | 27.7±1.6 | 10.18 | <0.001 |
| 嗅觉阈值测试( | 6.6±2.3 | 6.1±2.5 | 3.26 | 0.001 |
| 嗅觉识别测试( | 22.0±4.1 | 20.5±4.3 | 5.69 | <0.001 |
| TASKA( | 7.7±1.7 | 7.2±1.8 | 4.74 | <0.001 |
| TASKB( | 14.3±2.9 | 13.3±3.2 | 5.52 | <0.001 |
| 嗅觉回忆测试( | 14.4±2.7 | 13.3±2.6 | 6.87 | <0.001 |
| TASKA中出现的旧味道回忆( | 7.2±1.8 | 6.6±2.0 | 4.70 | <0.001 |
| TASKA中未出现的新味道回忆( | 7.2±1.9 | 6.6±2.0 | 4.91 | <0.001 |
| 嗅觉测评总分( | 43.2±7.1 | 39.9±7.2 | 7.34 | <0.001 |
| TG( | 1.7±1.4 | 1.7±1.3 | -0.23 | 0.820 |
| TC( | 4.5±1.2 | 4.6±1.2 | -2.00 | 0.046 |
| HDL-C( | 1.2±0.3 | 1.2±0.3 | -1.59 | 0.112 |
| LDL-C( | 2.6±0.8 | 2.7±0.8 | -2.00 | 0.045 |
| HbA1c( | 7.8±1.7 | 8.0±1.8 | -1.65 | 0.099 |
| FPG( | 7.3±2.3 | 7.5±2.2 | -1.35 | 0.177 |
| 2 hPG( | 13.9±4.1 | 14.0±3.8 | -0.31 | 0.756 |
| FCP( | 655.3±332.5 | 676.0±351.0 | -0.96 | 0.339 |
| 2 hCP( | 1 914.2±1 015.9 | 1 799.5±949.3 | 1.87 | 0.062 |
| HOMA2-IR( | 1.6±0.9 | 1.7±0.9 | -0.93 | 0.350 |
Table 1 General clinical data and olfactory test results of the subjects
| 项目 | 认知功能正常组(n=424) | 合并MCI组(n=639) | t(χ2)值 | P值 |
|---|---|---|---|---|
| 年龄( | 60.4±6.9 | 61.1±6.5 | -1.59 | 0.112 |
| 男性[例(%)] | 273(64.4) | 389(60.9) | 1.35a | 0.248 |
| 受教育年限( | 11.5±2.8 | 11.2±2.9 | -1.82 | 0.178 |
| 吸烟史[例(%)] | 131(30.9) | 208(32.6) | 0.32a | 0.571 |
| 饮酒史[例(%)] | 107(25.2) | 155(24.3) | 0.13a | 0.717 |
| 病程( | 10.5±7.7 | 10.6±7.4 | -0.13 | 0.897 |
| BMI( | 24.7±3.0 | 24.6±3.0 | 0.40 | 0.692 |
| WH R( | 0.93±0.07 | 0.93±0.06 | -0.01 | 0.992 |
| 收缩压( | 130±17 | 129±16 | 0.96 | 0.339 |
| 舒张压( | 81±10 | 80±10 | 1.05 | 0.293 |
| 合并高血压[例(%)] | 202(47.6) | 286(41.8) | 0.24a | 0.626 |
| 合并高脂血症[例(%)] | 184(43.4) | 250(39.1) | 0.01a | 0.930 |
| MoCA量表得分( | 27.1±1.2 | 23.3±1.8 | 42.41 | <0.001 |
| MMSE量表得分( | 28.6±1.2 | 27.7±1.6 | 10.18 | <0.001 |
| 嗅觉阈值测试( | 6.6±2.3 | 6.1±2.5 | 3.26 | 0.001 |
| 嗅觉识别测试( | 22.0±4.1 | 20.5±4.3 | 5.69 | <0.001 |
| TASKA( | 7.7±1.7 | 7.2±1.8 | 4.74 | <0.001 |
| TASKB( | 14.3±2.9 | 13.3±3.2 | 5.52 | <0.001 |
| 嗅觉回忆测试( | 14.4±2.7 | 13.3±2.6 | 6.87 | <0.001 |
| TASKA中出现的旧味道回忆( | 7.2±1.8 | 6.6±2.0 | 4.70 | <0.001 |
| TASKA中未出现的新味道回忆( | 7.2±1.9 | 6.6±2.0 | 4.91 | <0.001 |
| 嗅觉测评总分( | 43.2±7.1 | 39.9±7.2 | 7.34 | <0.001 |
| TG( | 1.7±1.4 | 1.7±1.3 | -0.23 | 0.820 |
| TC( | 4.5±1.2 | 4.6±1.2 | -2.00 | 0.046 |
| HDL-C( | 1.2±0.3 | 1.2±0.3 | -1.59 | 0.112 |
| LDL-C( | 2.6±0.8 | 2.7±0.8 | -2.00 | 0.045 |
| HbA1c( | 7.8±1.7 | 8.0±1.8 | -1.65 | 0.099 |
| FPG( | 7.3±2.3 | 7.5±2.2 | -1.35 | 0.177 |
| 2 hPG( | 13.9±4.1 | 14.0±3.8 | -0.31 | 0.756 |
| FCP( | 655.3±332.5 | 676.0±351.0 | -0.96 | 0.339 |
| 2 hCP( | 1 914.2±1 015.9 | 1 799.5±949.3 | 1.87 | 0.062 |
| HOMA2-IR( | 1.6±0.9 | 1.7±0.9 | -0.93 | 0.350 |
| 变量 | 赋值 |
|---|---|
| 发生MCI | 否=0,是=1 |
| 嗅觉测评总分 | 实测值(>42分=0,≤42分=1a) |
| 年龄 | 实测值 |
| 性别 | 男=1,女=2 |
| 受教育年限 | 实测值 |
| 糖尿病病程 | 实测值 |
| 吸烟史 | 否=0,是=1 |
| WH R | 实测值 |
| LDL-C | 实测值 |
| HbA1c | 实测值 |
| FPG | 实测值 |
| HOMA2-IR | 实测值 |
Table 2 Assignment table for multivariate Logistic regression analysis of olfactory total score and MCI risk in T2DM patients
| 变量 | 赋值 |
|---|---|
| 发生MCI | 否=0,是=1 |
| 嗅觉测评总分 | 实测值(>42分=0,≤42分=1a) |
| 年龄 | 实测值 |
| 性别 | 男=1,女=2 |
| 受教育年限 | 实测值 |
| 糖尿病病程 | 实测值 |
| 吸烟史 | 否=0,是=1 |
| WH R | 实测值 |
| LDL-C | 实测值 |
| HbA1c | 实测值 |
| FPG | 实测值 |
| HOMA2-IR | 实测值 |
| 模型1 | 模型2 | 模型3 | ||||
|---|---|---|---|---|---|---|
| HR(95%CI) | P值 | HR(95%CI) | P值 | HR(95%CI) | P值 | |
| 嗅觉测评总分分组(以高分组为参照) | ||||||
| 低分组 | 2.44(1.28~4.65) | 0.007 | 2.55(1.29~5.05) | 0.007 | 2.61(1.29~5.28) | 0.007 |
Table 3 Cox proportional hazards regression analysis of olfactory cut-off and MCI risk in T2DM patients
| 模型1 | 模型2 | 模型3 | ||||
|---|---|---|---|---|---|---|
| HR(95%CI) | P值 | HR(95%CI) | P值 | HR(95%CI) | P值 | |
| 嗅觉测评总分分组(以高分组为参照) | ||||||
| 低分组 | 2.44(1.28~4.65) | 0.007 | 2.55(1.29~5.05) | 0.007 | 2.61(1.29~5.28) | 0.007 |
| [1] |
|
| [2] |
|
| [3] |
|
| [4] |
|
| [5] |
|
| [6] |
|
| [7] |
|
| [8] |
|
| [9] |
|
| [10] |
|
| [11] |
|
| [12] |
|
| [13] |
|
| [14] |
丁群,张洲,于从从,等. 2型糖尿病患者嗅觉功能与认知功能关系的随访研究[J]. 中华糖尿病杂志, 2022, 14(12): 1404-1409. DOI: 10.3760/cma.j.cn115791-20220508-00204.
|
| [15] |
|
| [16] |
|
| [17] |
翁心植,邱鹤庚. 世界卫生组织(WHO)关于吸烟情况调查方法标准化的建议(节译)[J]. 心肺血管病杂志, 1984, 3(1): 21-26.
|
| [18] |
|
| [19] |
|
| [20] |
|
| [21] |
|
| [22] |
|
| [23] |
|
| [24] |
|
| [25] |
|
| [26] |
|
| [27] |
|
| [28] |
|
| [29] |
|
| [30] |
|
| [31] |
|
| [32] |
|
| [33] |
|
| [34] |
|
| [1] | Hubei Provincial Clinical Medical Research Center for Endocrinology and Metabolic Diseases, Metabolic Health and Disease Prevention & Professional Committee, Wuhan Preventive Medicine Association, Tongji Hospital Endocrine Subspecialty Alliance, PENG Ting, ZHANG Yanchao, LIU Xu, LI Chan. Expert Consensus on Comprehensive Management of Diabetes-associated Cognitive Dysfunction (2026 Edition) [J]. Chinese General Practice, 2026, 29(36): 5313-5325. |
| [2] | LI Jinting, GAO Aiju. Association between Weight-adjusted Waist Index and Depression Risk in Middle-aged and Older Chinese Adults [J]. Chinese General Practice, 2026, 29(34): 5071-5077. |
| [3] | ZHANG Ji, LI Ling, ZHOU Jie, WU Yanli, JI Wei, LIU Tao. A Prospective Cohort Study on Relationship between Lipid Accumulation Product and Incidence of Metabolic Syndrome in Adults [J]. Chinese General Practice, 2026, 29(22): 3138-3145. |
| [4] | WANG Chenyu, WANG Xiaoyan, ZHANG Lixiu, WANG Lina. Advances in Community Screening and Diagnostic Management Strategies for Individuals with Mild Cognitive Impairment [J]. Chinese General Practice, 2026, 29(08): 1037-1043. |
| [5] | ZHANG Yanjing, ZHOU Chunhua, LI Xiaodong, LIU Yan, WANG Jing, YU Jing. Study on the Clinical Value of a Risk Prediction Model for Venlafaxine Plasma Concentration Exceeding the Safety Threshold [J]. Chinese General Practice, 2026, 29(06): 777-782. |
| [6] | LI Shunan, ZHANG Shiyan, DENG Yanan, HU Danqing, ZHENG Yuxin, LI Danyang, LI Candong. An Analysis of Trends and Prediction of Disease Burden for Type 2 Diabetic Nephropathy from 1990 to 2021 in China [J]. Chinese General Practice, 2025, 28(33): 4214-4226. |
| [7] | ZHANG Yuan, CHEN Guanhua, LYU Shanshan, JING Yali. Relationship between Thyroid Hormone Sensitivity Indices and Osteoporosis in Patients with Normal Thyroid Function Type 2 Diabetes Mellitus [J]. Chinese General Practice, 2025, 28(29): 3653-3659. |
| [8] | HAN Xiao, LI Qiyu, GE Pu, FAN Siyuan, LIU Diyue, WU Yibo, ZHANG Qingshuang. The Impact of Behavioral Lifestyle on Quality of Life in Hypertensive Patients [J]. Chinese General Practice, 2025, 28(26): 3248-3258. |
| [9] | YIN Jiahui, YANG Xinhui, WANG Jingjing, ZHANG Yajing, WANG Lijuan, FU Zuodi, KONG Xiangshuang, GUO Guangxia, LI Yufeng. Predictive Value Waist-to-height Ratio, Waist-to-hip Ratio and Body Mass Index for Metabolic Syndrome [J]. Chinese General Practice, 2025, 28(26): 3258-3263. |
| [10] | WEI Jiaohua, PENG Huiru, PENG Jianye, TAN Wenting, HUANG Jine, FANG Li. Expression of the Serum MOTS-c and Its Correlation with Atrial Remodeling in Patients with Atrial Fibrillation [J]. Chinese General Practice, 2025, 28(26): 3271-3276. |
| [11] | LI Jiaxin, LIU Zhonghui, XIE Shuo, FU Zhifang, SUN Dan, JIAO Hongmei. Trajectory in Biomarkers of Metabolic and Inflammatory States as Early Predictors of Chronic Critical Illness in Aging Patients [J]. Chinese General Practice, 2025, 28(24): 2993-2999. |
| [12] | LIU Meixia, YIN Jinnian, WU Mei, YANG Xing, ZHOU Quanxiang, YANG Jingyuan. Impact of Body Mass Index on the Association of Triglyceride Glucose Index with Cognitive Function: a Cross-sectional Study in Rural Older Adults in Guizhou Province [J]. Chinese General Practice, 2025, 28(22): 2806-2812. |
| [13] | SUN Qinyu, DENG Yifan, HE Shenghu, ZHANG Jing. Study of the Predictive Value of Neutrophil/Lymphocyte Ratio, Monocyte/High-density Lipoprotein Cholesterol Ratio, and the Combination of the Two for Contrast Nephropathy after Emergency PCI in Patients with Acute ST-segment Elevation Myocardial Infarction [J]. Chinese General Practice, 2025, 28(15): 1891-1897. |
| [14] | LI Ruitong, YUE Yuchuan, GU Xujie, XIONG Lingling. Risk Prediction Models for Refractory Mycoplasma Pneumoniae Pneumonia in Children: a Systematic Review [J]. Chinese General Practice, 2025, 28(09): 1105-1114. |
| [15] | CHEN Shenglan, ZHENG Yongtao, HU Wangcheng, NI Zuowei, XIA Bing, YE Chunmei, DU Chixin, CHEN Xiaodan. Risk Prediction Model for High Myopia in Primary and Secondary School Students: Based on Nested Case-control Study [J]. Chinese General Practice, 2025, 28(09): 1115-1121. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||